These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17063871

  • 1. [The positive rate of lupus anticoagulant according to the each understanding disease in our hospital].
    Omote M, Yoshida T, Asakura H, Ontachi Y, Hayashi T, Morishita E, Yamazaki M, Fujita S, Nakao S.
    Rinsho Byori; 2006 Sep; 54(9):903-9. PubMed ID: 17063871
    [Abstract] [Full Text] [Related]

  • 2. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T.
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T, Julkunen H, Vaarala O, Leirisalo-Repo M, Stephansson E, Vahtera E, Palosuo T, Myllylä G.
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [Abstract] [Full Text] [Related]

  • 4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 5. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 6. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T.
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [Abstract] [Full Text] [Related]

  • 7. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
    Galli M, Finazzi G, Norbis F, Marziali S, Marchioli R, Barbui T.
    Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA, Krilis SA.
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [Abstract] [Full Text] [Related]

  • 9. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM, Rodrigues CA, Noguti MA, Matos MF, da Silveira RC, Ribeiro AA, Lourenço DM.
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [Abstract] [Full Text] [Related]

  • 10. [Laboratory diagnosis of lupus anticoagulant].
    Swadźba J, Musiał J, Jankowski M, Bednarczyk M, Dyczek A, Szczeklik A.
    Pol Merkur Lekarski; 1996 Nov; 1(5):359-62. PubMed ID: 9273219
    [Abstract] [Full Text] [Related]

  • 11. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A, Bartlett RP, Moder KG, Chang-Miller A, Cardel LK, Heit JA, Homburger HA, Petterson TM, Christianson TJ, Nichols WL.
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy.
    Awodu OA, Olayemi EE, Bazuaye GN, Onunu AN.
    Indian J Pathol Microbiol; 2010 Apr; 53(1):47-9. PubMed ID: 20090221
    [Abstract] [Full Text] [Related]

  • 15. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
    Jennings I, Kitchen S, Woods TA, Preston FE, Greaves M.
    Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
    [Abstract] [Full Text] [Related]

  • 16. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].
    Raleigh-Rosendo R, Diez-Ewald M, Vizcaíno G, Fereira H, Arteaga-Vizcaíno M, Arreaza M.
    Invest Clin; 1990 May; 31(1):45-55. PubMed ID: 2128614
    [Abstract] [Full Text] [Related]

  • 17. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN.
    Thromb Haemost; 1990 Nov 30; 64(3):478-84. PubMed ID: 2128977
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prevalence of lupus anticoagulant, autoimmune hemolysis, thrombocytopenia and disorders of platelet function in unselected patients with SLE].
    Söhngen D, Specker C, Wehmeier A, Kiefel V, Rathmer L, Söhngen R, Schneider W.
    Beitr Infusionsther; 1992 Nov 30; 30():469-73. PubMed ID: 1284763
    [Abstract] [Full Text] [Related]

  • 20. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI.
    Korean J Lab Med; 2009 Dec 30; 29(6):497-504. PubMed ID: 20046079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.